İlkay KARAOĞLAN, Yasemin ZER, Mustafa NAMIDURU

GSBL pozitif Escherichia coli ve Klebsiella pneumoniae suşlarında tigesiklinin in-vitro etkinliği

Yoğun bakım ünitesindeki hastalara ait örneklerden izole edilen genişlemiş spektrumlu beta-laktamaz pozitif Escherichia coli ve Klebsiella pneumoniae suşlarında tigesiklinin in-vitro etkinliği araştırılmıştır. Tigesiklinin bu suşlara etkili bir antibiyotik olduğu sonucuna varılmıştır

Anahtar Kelimeler:

Kültür ortamı, Escherichia coli, In vitro, Klebsiella pneumoniae, Mikrobiyal duyarlılık testleri, Klinik laboratuvar teknikleri

The in-vitro activity of tigecycline on ESBL producing Escherichia coli and Klebsiella pneumoniae strains

In-vitro activity of tigecyline was investigated against extended-spectrum beta-lactamase positive Escherichia coli and Klebsiella pneumoniae strains isolated from patients in the intensive care unit. Tigecyline proved to be an effective antimicrobial against these strains

Keywords:

Culture Media, Escherichia coli, In Vitro, Klebsiella pneumoniae, Microbial Sensitivity Tests, Clinical Laboratory Techniques,

PDF

___

1. Bauer G, Berens C, Projan SJ, Hillen W: Comparison of tetracycline and tigecycline binding to ribosomes mapped by dimethylsulphate and drugdirected Fe2+ cleavage of 16S rRNA, J Antimicrob Chemother 2004;53(4):592-9.
2. Bouchillon SK, Hoban DJ, Johnson BM et al: In vitro activity of tigecycline against 3989 Gram negative and gram positive clinical isolates from the United States. Tigecyline Evaluation and Surveillance Trial (TEST program; 2004), Diagn Microbiol Infect Dis 2005;52(3):173-9.
3. Fritsche TR, Strabala PA, Sader HS, Dowzicky MJ, Jones RN: Activity of tigecyline tested against a global collection of Enterobacteriaceae, including tetracycline resistant isolates, Diagn Microbiol Infect Dis 2005;52(3):209-13.
4. Kaya I, Göker G, Bal Kayacan Ç, Gürler N: Yoğun bakım isolatı Gram negatif bakterilerde tigesiklin duyarlılığı, ANKEM Derg 2007;21(3):142-5.
5. Nathwani D: Tigecyline: Clinical evidence and formulary positioning, Int J Antimicrob Agents 2005;25(3):185-92.
6. Petersen PJ, Jocobus NV, Weiss WJ, Sum PE, Testa RT: In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butglycylamido derivative of minocyline (GAR-936), Antimicrob Agents Chemother 1999;43(4):738-44.
7. Wheyt Pharmaceuticals Inc.: Tygacil Product Insert, Philadelphia (PA).
8. Zhanel GG, Homenuik K, Nichol K et al: The glycylcyclines, a comparative review with tetracylines, Drugs 2004;64(1):63-88.